Early identification and heritability of mild cognitive impairment

William S Kremen1, Amy J Jak, Matthew S Panizzon

  • 1Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA, Center of Excellence for Stress and Mental Health, VA San Diego Healthcare System, La Jolla, CA, USA, Psychology Service, VA San Diego Healthcare System, La Jolla, CA, USA, Computational Science Research Center, San Diego State University/Claremont Graduate University, San Diego, CA, USA, Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA, Department of Public Health, University of Helsinki, Helsinki, Finland, Department of Statistics, St Louis University, St Louis, MO, USA, Research Service, VA St Louis Healthcare System, St Louis, MO, USA and Department of Psychology, Boston University, Boston, MA, USA.

Abstract

Insights

Mild cognitive impairment (MCI) is identifiable in middle age and linked to lower early cognitive ability. MCI heritability is comparable to Alzheimer's disease (AD), suggesting its use in genetic studies.

Area of Science:

  • Neuroscience
  • Genetics
  • Cognitive Aging

Background:

  • Early identification of mild cognitive impairment (MCI) is crucial for Alzheimer's disease (AD) intervention.
  • Alzheimer's disease (AD) is highly heritable, but the heritability of MCI remains understudied.
  • This study investigates MCI prevalence, association with general cognitive ability (GCA), and heritability in midlife adults.

Purpose of the Study:

  • To estimate MCI prevalence and heritability in adults in their 50s.
  • To examine the association between MCI and premorbid general cognitive ability (GCA).
  • To assess the suitability of MCI as a phenotype for genetic studies.

Main Methods:

  • Examined 1126 twins aged 51-59 from the Vietnam Era Twin Study of Aging (VETSA).
  • Assessed six neurocognitive domains using tests designed to avoid ceiling effects.
  • Adjusted for general cognitive ability (GCA) measured in early adulthood to differentiate MCI from low overall ability.

Main Results:

  • Prevalence rates for MCI varied significantly across different definitions.
  • MCI was associated with lower premorbid general cognitive ability (GCA).
  • Heritability estimates for MCI ranged from .40 to .48, comparable to AD.

Conclusions:

  • Mild cognitive impairment (MCI) can be identified in individuals under 60 using sensitive cognitive assessments.
  • Premorbid GCA is a risk factor, but declining GCA after early adulthood suggests additional pathological processes.
  • MCI heritability supports its use in genetic association studies for neurodegenerative diseases.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
1.1K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
687